疏水性药物颗粒在体外胃肠液中采用复杂的生物分子冠状
Anas Aljabbari1, Shinji Kihara1, Thomas Thymann2
1Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark.
概括
药物颗粒上的胃肠 (GI) 生物分子冠状体取决于药物的特性和位于胃肠道内的位置. 肠液蛋白质主导着冠状体,影响药物行为.
科学领域:
- 制药科学 制药科学
- 生物材料科学 生物材料科学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 血液粒子界面上的生物分子冠状体得到了很好的研究.
- 在摄入药物颗粒上的胃肠道 (GI) 生物分子冠状体是最近的一个研究重点.
- 了解这种冠状病毒对于药物配方和预测体内行为至关重要.
研究的目的:
- 为了研究药物颗粒上GI生物分子冠状的组成.
- 为了确定药物身份和固态形式对冠状形成的影响.
- 分析不同 ex vivo 猪肠道液体 (胃,肠道,结肠) 中的冠状形成.
主要方法:
- 使用了猪的胃,肠和结肠液体 (PGF,PIF,PCF).
- 采用液体染色学-并联质谱学 (LC-MS/MS) 蛋白质组学.
- 研究的克洛特里马 (CMZ),里托纳维尔 (RTV) 和印梅他辛 (IND) 颗粒,包括无形和晶体形式.
主要成果:
- 胃肠道冠状元的组成是分区特定的,PGF显示了最多的蛋白质.
- PIF冠状很快达到平衡,并且独立于时间.
- 连续暴露表明PIF蛋白质在冠状病毒中占主导地位,无论之前的暴露情况如何.
- 在药物 (CMZ,RTV与IND) 和IND固态形式 (无形与晶体) 之间,冠状病毒的组成有所不同.
- 无形IND形成了比晶体IND更多样化的冠状.
结论:
- 药物颗粒的身份和固态形式显著影响肠道液体中的生物分子冠状体组成.
- 肠液中的蛋白质在冠状体中起着主导作用,特别是在连续暴露后.
- 这些发现为设计针对胃肠道的药物输送系统提供了关键的见解.
相关概念视频
Factors Influencing Drug Absorption: Physicochemical Parameters
816
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
816
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
3.0K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.0K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
498
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
498
Methods for Studying Drug Absorption: In vitro
571
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
571
Factors Influencing Drug Absorption: Drug Dissolution
1.1K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193


